Long- term therapy with gonadoliberin analogues in patient with ovarian cancer.

ESGO eAcademy, Session Speakers, 191006

High grade serous ovarian cancer stage IV, multiple relapses

ESGO eAcademy, Session Speakers, 191003

Ovarian Cancer in Pregnancy

ESGO eAcademy, Session Speakers, 190595

Look into the future: Medical treatment of ovarian cancer in 2026

ESGO eAcademy, Ignace B. Vergote, 173572

Immunotherapy in gynecological malignancies

ESGO eAcademy, An Coosemans, 173570

Why do studies of targeted treatment fail?

ESGO eAcademy, Jonathan A Ledermann, 173568

Targeting PARP: Mechanisms of action, available evidence, selection of patients, management of toxicities

ESGO eAcademy, Jonathan A Ledermann, 173567

Targeting tyrosine kinases

ESGO eAcademy, Jonathan A Ledermann, 173566

Molecular pathways in cervical cancer

ESGO eAcademy, Heidi Lyng, 173565

Molecular pathways in endometrial cancer

ESGO eAcademy, Henrica Maria Johanna Werner, 173564

Molecular pathways of low-grade ovarian cancer

ESGO eAcademy, Kristina Lindemann, 173563

Molecular pathways of high grade ovarian cancer

ESGO eAcademy, Adriaan Vanderstichele, 173562

Uterine sarcoma study

ESGO eAcademy, Frederic Amant, 173560

Ultrasound guided procedures

ESGO eAcademy, Michal Zikan, 173920

Ovarian cancer staging

ESGO eAcademy, Daniela Fischerova, 173919

Endometrial cancer diagnosis and staging

ESGO eAcademy, Elisabeth Epstein, 173918

Cervical cancer staging

ESGO eAcademy, Antonia Testa, 173917

Abdominal scan

ESGO eAcademy, Daniela Fischerova, 173916

Pelvic imaging

ESGO eAcademy, Daniela Fischerova, 173915

Introduction

ESGO eAcademy, David Cibula, 173914

PMMR in endometrial cancer - Part one - Compartmental lymphatic network of uterine corpus and its drainage

ESGO eAcademy, K. Rainer Kimmig, 166631

PMMR in endometrial cancer - Part two - Surgical technique

ESGO eAcademy, K. Rainer Kimmig, 166632

Highlights about Radiation Oncology in Cervical Cancer

ESGO eAcademy, Richard Poetter, 150847

Adjuvant Treatment and Place of Radiation Therapy in Vulvar Cancer

ESGO eAcademy, Carien L. Creutzberg, 150846

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

ESGO eAcademy, Mansoor Raza Mirza, 154789

New ESGO Guidelines of Management of Vulvar Cancer

ESGO eAcademy, Ate G.J. Van Der Zee, 150845

How to Stage Locally Advanced Cervical Cancer (Radiological and Surgical) before Chemoradiation Therapy

ESGO eAcademy, Sebastien Gouy, 150844

Management of the Clear Cell Ovarian Carcinoma

ESGO eAcademy, Keiichi Fujiwara, 150843

Phase 2: What Information Can We Derive? Rational, Design and Objectives

ESGO eAcademy, Jonathan A Ledermann, 150268

Surrogate Endpoints

ESGO eAcademy, Paolo Bruzzi, 150266

Phase 1/1B: What Information Can We Derive? Rational, Design and Objectives

ESGO eAcademy, Cristiana Sessa, 150267

Statistical Plans, Interim Analysis and Subgroup Analysis

ESGO eAcademy, Paolo Bruzzi, 150265

Vulvar Cancer: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Fabio Landoni, 150264

Endometrial Cancer: What Do We Know? What Don't We Know ? What Should Be Investigated?

ESGO eAcademy, Eric Pujade-Lauraine, 150263

Uterine Sarcoma: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Andrés Poveda, 150262

Cervical Cancer: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Christian Marth, 150261

Welcome & Introduction

ESGO eAcademy, Nicoletta Colombo, 150269

New Classification of Uterine Sarcoma

ESGO eAcademy, Sabrina Croce, 147380

Gastric-type Mucinous Cervical Adenocarcinoma

ESGO eAcademy, Mojgan Devouassoux, 148332

Vulvovaginal Glandular Neoplasia

ESGO eAcademy, Mojgan Devouassoux, 148333

Pathology of Clear Cell Ovarian Tumors

ESGO eAcademy, Ester Oliva, 147379

New Classification and Molecular of Endometrial Cancers

ESGO eAcademy, Sigurd Lax, 147381

Pathologic Characteristics of Mucinous Tumors (Borderline and Invasive: Infltrative/expansile Subtypes)

ESGO eAcademy, Sigurd Lax, 147383

Aortic Extraperitoneal Lymphadenectomy

ESGO eAcademy, Lucas Minig, 148602

Peritoneal Suture During Extraperitoneal Lymphadenectomy

ESGO eAcademy, Lucas Minig, 148603

Sentinel Node Detection

ESGO eAcademy, Lucas Minig, 148604

Dissection of the Avascular Spaces of the Pelvis

ESGO eAcademy, Lucas Minig, 148605

Pelvic Lymphadenectomy

ESGO eAcademy, Lucas Minig, 148606

Radical Oophorectomy with Colorectal Resection for Advanced Ovarian Cancer

ESGO eAcademy, Lucas Minig, 148607

Ileo-Colic Resection with Anastomosis for Advanced Ovarian Cancer

ESGO eAcademy, Lucas Minig, 148608

Pathological and Molecular Classification of Epithelial Ovarian Cancer

ESGO eAcademy, Sigurd Lax, 147382

Restoring the Function of Mutated P53 - a Major Contribution to Carcinogenesis

ESGO eAcademy, John A Green, 147116

Genetic Testing in Ovarian Cancer Patients: How Far Should We Go

ESGO eAcademy, Charlie Gourley, 147115

Adjuvant Therapeutic Approaches by Histological Subtype with Implications for Treatment

ESGO eAcademy, Jonathan A Ledermann, 147114

Prophylactic Surgery in High Risk Population

ESGO eAcademy, Christina Fotopoulou, 147112

Laser Skinning Vulvectomy

ESGO eAcademy, Michael G. Halaska, 147110

LEEP/LLETZ and Needle Conization

ESGO eAcademy, Ilker Selcuk, 147109

Cold Knife Conization and Sturmdorf Technique

ESGO eAcademy, Ignacio Zapardiel, 147108

Simple Solutions for Developing Countries for Breast Cancer Screening

ESGO eAcademy, Murat Gultekin, 147106

Current Situation of Breast Cancer Screening Startegies in Europe and Around the World

ESGO eAcademy, Larry von Karsa, 147105

Evaluation of Mammography for the Detection of Breast Cancer in Screening Programs

ESGO eAcademy, Peter Dean, 147104

Molecular Cancer Genetics

ESGO eAcademy, Henrica Maria Johanna Werner, 147103

Endometrial Cancers Prevention and Screening Methods

ESGO eAcademy, Thierry A.M. Van Den Bosch, 147102

Chemoprevention of Endometrial Cancers

ESGO eAcademy, Pauline Wimberger, 147100

Obesity and Gynaecological Cancers

ESGO eAcademy, Maria Kyrgiou, 147099

Follow-up and Treatment of Recurrences

ESGO eAcademy, Vesna I. Kesic, 147098

Should CIN2 Lesions Be Treated and When?

ESGO eAcademy, Maria Kyrgiou, 147097

Screening after Vaccination

ESGO eAcademy, Jack Cuzick, 147096

Novel Molecular Techniques in Screening & Diagnosis & Prediction

ESGO eAcademy, Jack Cuzick, 147094

Cytology vs. HPV for Primary Screening

ESGO eAcademy, Marc Arbyn, 147093

Cervical Cancer Screening in Low and High Resource Settings

ESGO eAcademy, Partha Basu, 147092

HPV Prophylactic Vaccines: Lessons Learned from 10 Years Experiences

ESGO eAcademy, Xavier Bosch, 147090

HPV Related Cancers: the Comparative Figures in the World

ESGO eAcademy, Partha Basu, 147089

The Human Papillomavirus Types and the Type-specific Risks for Disease

ESGO eAcademy, Joakim Dillner, 147088

Quality Assurance for the Surgical Management of Ovarian Cancer and ESGO Certification

ESGO eAcademy, Denis Querleu, 139309

Goals and Limits of Surgery in Advanced Ovarian Cancer

ESGO eAcademy, Luis M. Chiva, 139308

Combining a Surgical and Treatment Question in the Same Trial. Is It Feasible?

ESGO eAcademy, Mansoor Raza Mirza, 135850

Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: a Unique Opportunity for Traslational Research

ESGO eAcademy, Sandro Pignata, 135849

Algorithm To Select Patients for Primary Cytoreductive Surgery versus Neoadjuvant Chemotherapy

ESGO eAcademy, Christian Marth, 135848

Quality Assessment in Ovarian Cancer Surgery

ESGO eAcademy, Andreas Du Bois, 135847

Immune Check Points

ESGO eAcademy, Iain McNeish, 135846

Cell Cycle Check Points

ESGO eAcademy, Cristiana Sessa, 135845

P53

ESGO eAcademy, Nicole Concin, 135844

Defective DNA Repair as a Target in Ovarian Cancer

ESGO eAcademy, Ignace B. Vergote, 135843

Results from Group C: Lights and Shadows on Rare Ovarian Tumors

ESGO eAcademy, Nicoletta Colombo, 135842

Results from Group D: Lights and Shadows on Stratification Factors, Control Groups and Endpoints in Recurrent Disease

ESGO eAcademy, Eric Pujade-Lauraine, 135841

Results from Group B: Lights and Shadows on Control Groups and Endpoints in Front Line

ESGO eAcademy, Nicoletta Colombo, 135840

How To Organize a Consensus Conference: Methodology and SOPs

ESGO eAcademy, Andreas Du Bois, 135838

Results from Group A: Lights and Shadows on Stratification Factors (Clinical, Pathologic and Molecular) in Front Line

ESGO eAcademy, Andrés Poveda, 135839

Retroperitoneal Paraaortic Lymphadenectomy

ESGO eAcademy, Eric Leblanc, 138191

Laparoscopic Management of Deep Pelvic Endometriosis

ESGO eAcademy, Cagatay Taskiran, 138192

Laparoscopic Cerclage in Patients After RVT

ESGO eAcademy, Christhardt Koehler, 138193

Upper Abdominal Surgery: Liver, Porta Hepatis, Lesser Sack

ESGO eAcademy, Cagatay Taskiran, 138194

Routine Use of Vicryl Mesh to Separate Compartements after Exenterative Surgery

ESGO eAcademy, Christhardt Koehler, 138184

Simplifying Neovaginal Reconstruction by Vertical Rectus Abdominis Myocutaneous Flap after Pelvic Exenteration

ESGO eAcademy, Ignacio Zapardiel, 138185

Anatomy of the Upper Abdominal Surgery

ESGO eAcademy, Christina Fotopoulou, 138186

Retroperitoneal Anatomy

ESGO eAcademy, Ali Kucukmetin, 138187

Revisiting Abdominal Wall Vascular Anatomy, Suggested Technique of Assessing and Treating Port Related Epigastric Vessels Injuries following a case of dramatic postoperative hemorrhage

ESGO eAcademy, oudai ALI, 138188

TachoSil in Onco-Gynecology/Obstetrics/Tissue Sealing

ESGO eAcademy, Alexander W. Reinthaller, 138189

Robotic Paraaortic Lymphadenectomy Using Indocyanine Green

ESGO eAcademy, Pedro Ramirez, 138190